World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Dr
DeepMind
Showing your local timezone
Schedule
Tuesday, March 12, 2024
2:00 PM Europe/London
Seminar location
No geocoded details are available for this content yet.
Format
Past Seminar
Recording
Not available
Host
NeuroAI UCL
Seminar location
No geocoded details are available for this content yet.
Nonstationarity presents a variety of challenges for machine learning systems. One surprising pathology which can arise in nonstationary learning problems is plasticity loss, whereby making progress on new learning objectives becomes more difficult as training progresses. Networks which are unable to adapt in response to changes in their environment experience plateaus or even declines in performance in highly non-stationary domains such as reinforcement learning, where the learner must quickly adapt to new information even after hundreds of millions of optimization steps. The loss of plasticity manifests in a cluster of related empirical phenomena which have been identified by a number of recent works, including the primacy bias, implicit under-parameterization, rank collapse, and capacity loss. While this phenomenon is widely observed, it is still not fully understood. This talk will present exciting recent results which shed light on the mechanisms driving the loss of plasticity in a variety of learning problems and survey methods to maintain network plasticity in non-stationary tasks, with a particular focus on deep reinforcement learning.
Clare Lyle
Dr
DeepMind
Contact & Resources
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe